ALPS

MKT CAP:$155M

Alps Group Inc

Market Cap

$155M

Healthcare·Biotechnology· Malaysia·NASDAQ

Healthcare·Biotechnology·NASDAQ

Stock Price

$0.92+$0.00 (+0.44%)

Apr 23, 2026

Company Details

Alps Group Inc is an integrated biotechnology platform providing research and development, medical services, and wellness solutions focused on advanced therapies. The company aims to create a fair healthcare ecosystem with accessible predic...

CEO

Seng Kong Tham

IPO Date

Oct 31, 2025

Website

alps-holdings.com

Key Metrics TTM

Revenue

$3M

— YoY

Net Income

-$68M

EPS (Diluted)

-$0.41

Free Cash Flow

-$962.4K

Revenue / Share

$0.96

Gross Margin

38.6%

Operating Margin

-1983.1%

Net Margin

-2004.5%

FCF Margin

-28.5%

P/S

46.0x

P/E

—

Earnings Reports

Q4 2025

Oct 31, 2025

$3MEPS $0.27

Q3 2025

Oct 31, 2025

$0EPS -$0.24

Q2 2025

Jun 29, 2025

$0EPS -$0.24

Q1 2025

Mar 30, 2025

$0EPS -$0.20

FY 2024

Mar 31, 2025

$3MEPS -$0.68

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 22	-$17M	-$120M	-$285.4K
Q4 23	$0	$0	-$326.2K
Q1 24	$0	$0	-$599.5K
Q2 24	$0	$0	-$469.6K
Q3 24	$0	$0	-$337.6K
Q4 24	$0	$0	-$428.3K
Q4 25	$3M	$1M	-$65M
Q1 25	$0	$0	-$483.9K
Q2 25	$0	$0	-$451.1K
Q3 25	$0	$0	-$450.8K

Valuation

Quarter	P/S	P/E
Q4 22	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	10860.9x
Q3 24	—	—
Q4 24	—	—
Q4 25	70.1x	—
Q1 25	70.1x	—
Q2 25	70.1x	—
Q3 25	70.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 23	-$228.0K	-$228.0K
Q1 24	-$885.8K	-$885.8K
Q2 24	-$673.9K	-$673.9K
Q3 24	-$197.9K	-$197.9K
Q4 24	-$281.7K	-$281.7K
Q1 25	-$160.0K	-$160.0K
Q2 25	-$270.4K	-$270.4K
Q3 25	-$250.3K	-$250.3K

Capital Expenditures

Quarter	CapEx
Q4 23	$0
Q1 24	$3
Q2 24	$0
Q3 24	$0
Q4 24	$4
Q1 25	$0
Q2 25	$0
Q3 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 24	+100.0%	+102.0%
Q4 24	—	+31.3%
Q4 25	—	+11382.3%
Q1 25	—	+3.0%
Q2 25	—	+33.6%
Q3 25	—	+5.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$0	—
Q4 24	$0	—
Q1 25	$0	0.0%
Q2 25	$0	—
Q3 25	$0	—

OpEx Breakdown

Quarter	G&A	SG&A
Q4 22	$5M	—
Q4 23	—	$276.2K
Q1 24	—	$603.5K
Q2 24	—	$419.6K
Q3 24	—	$287.6K
Q4 24	—	$259.0K
Q4 25	$67M	—
Q1 25	—	$270.3K
Q2 25	—	$333.8K
Q3 25	—	$300.4K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$7M	$0	$7M
Q1 23	$7M	$0	$7M
Q4 23	$79.1K	$0	$79.1K
Q1 24	$6.9K	$0	$6.9K
Q2 24	$143.2K	$0	$143.2K
Q3 24	$65.2K	$0	$65.2K
Q4 24	$253.5K	$0	$253.5K
Q1 25	$3.5K	$0	$3.5K
Q4 25	$3M	$0	$3M
Q2 25	$3M	$0	$3M
Q3 25	$357.7K	$0	$357.7K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 22	54M	—	—
Q4 23	6M	-88.8%	—
Q1 24	6M	0.0%	—
Q2 24	6M	0.0%	—
Q3 24	6M	0.0%	-88.8%
Q4 24	6M	-7.8%	-7.8%
Q4 25	166M	+2905.4%	+2669.8%
Q1 25	4M	-97.8%	-38.0%
Q2 25	4M	-1.6%	-39.0%
Q3 25	4M	-4.0%	-36.5%

Shares Outstanding